sSitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API     

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 

       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Ergonovineis part of a group of medicines called ergot alkaloids

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
   Pharmaceuticals API List
   Chemicals >>>
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us

Ergonovine CAS No: 60-79-7











HOME >> Chemicals >> Chemicals List 1 >> Ergonovine

CAS Number 60-79-7

Ergonovineis part
This medication increases uterine contractions resulting in decreased uterine bleeding. It is used to treat or prevent uterine bleeding. It has also been used to treat migraine headaches.

Ergonovineis part of a group of medicines called ergot alkaloids. It is used to treat or prevent excessive bleeding after child birth.


Synonyms: 9,20-didehydro-N-(alpha-(hydroxymethyl)ethyl)-6-m-ethylergoline-8-beta-carboxamide, ergoline-8-carboxamide, N-((S)-2-hydroxy-1-methylethyl)-lysergamide, ergoatetrine, ergobasine, ergoklinine, ergotocine, ergometrine, ermetrine, margonovine, neofemergen, secacornin, secometrin Use:

Molecular formula: C19H23N3O2

CAS No: 60-79-7
EINECS No: 200-485-0

Ergonovine formula: C19H23N3O2Physical data

Appearance: solid
Melting point:
Boiling point:
Vapour density:
Vapour pressure:
Density (g cm-3):
Flash point:
Explosion limits:
Autoignition temperature:
Water solubility:


Stable. Incompatible with strong oxidizing agents.


Toxic if swallowed, inhaled or absorbed through the skin. May cause reproductive damage.

Personal protection

Safety glasses, gloves, good ventilation.

It has a medical use in obstetrics to facilitate delivery of the placenta and to prevent bleeding after childbirth by causing smooth muscle tissue in the blood vessel walls to narrow, thereby reducing blood flow. It is usually combined with oxytocin (syntocinon) as syntometrine.

It can induce spasm of the coronary arteries.

This is sometimes used in the differential diagnosis of angina.



Note /Government Notification: These chemicals are designated as those that are used in the manufacture of the controlled substances and are important to the manufacture of the substances. For any (Control Substance) products Import and Export *** subjected to your country government laws /control substance ACT.
Information:  The information on this web page is provided to help you to work safely, but it is intended to be an overview of hazards, not a replacement for a full Material Safety Data Sheet (MSDS). MSDS forms can be downloaded from the web sites of many chemical suppliers. ,also that the information on the PTCL Safety web site, where this page was hosted, has been copied onto many other sites, often without permission. If you have any doubts about the veracity of the information that you are viewing, or have any queries, please check the URL that your web browser displays for this page. If the URL begins " Benzoate.htm/" the page is maintained by the Safety Officer in Physical Chemistry at Oxford University. If not, this page is a copy made by some other person and we have no responsibility for it.
The Controlled Substances Act (CSA) was enacted into law by the Congress of the United States as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970.[1] The CSA is the federal U.S. drug policy under which the manufacture, importation, possession, use and distribution of certain substances is regulated. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs

Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo


Chemical Manufacturer In India

Anthranilic acid

Denatonium Benzoate




Hydroiodic acid






Gamma butyrolactone









Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact
us and we will respond to your inquiry as quickly as possible.